Evidence map›Paper›PMID 27721366›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2016

Genetic Screening and Analysis of LKB1 Gene in Chinese Patients with Peutz-Jeghers Syndrome.

Chunyan Chen, Xiaomei Zhang, Deqiang Wang, Fangyu Wang, Jian Pan, Zhenkai Wang, Chang Liu, Lin Wu, Heng Lu, Nan Li and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Chunyan ChenDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Xiaomei ZhangLaboratory of Genetics and Molecular Biology, Jiangsu Province Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China (mainland).
Deqiang WangThe Cancer Therapy Center, Affiliated Hospital of Jiangsu University, Nanjing, Jiangsu, China (mainland).
Fangyu WangDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Jian PanDepartment of Gastroenterology, Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China (mainland).
Zhenkai WangDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Chang LiuDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Lin WuDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Heng LuDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Nan LiDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Juan WeiDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Hui ShiDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Haijun WanDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Ming ZhuLaboratory of Genetics and Molecular Biology, Jiangsu Province Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China (mainland).
Senqing ChenLaboratory of Genetics and Molecular Biology, Jiangsu Province Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China (mainland).
Yun ZhouDepartment of Medicine, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China (mainland).
Xin ZhouDepartment of General Surgery, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China (mainland).
Liu YangDepartment of General Surgery, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China (mainland).
Jiong LiuDepartment of Gastroenterology and Hepatology, Jinling Hospital, Nanjing, Jiangsu, China (mainland).
Jiangsu Cancer Hospital · CNJinling Institute of Technology · CNNanjing General Hospital of Nanjing Military Command · CNJiangsu University · CNNanjing Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Peutz-Jeghers syndrome (PJS) is an autosomal dominant genetic disease. It severely decreases patient quality of life and leads elevated cancer risk. Germline mutation of LKB1 is the leading cause of familial PJS. MATERIAL AND METHODS To characterize the germline mutation of LKB1 gene in Chinese familial and sporadic PJS patients, 14 PJS families, 5 sporadic PJS patients, and 250 healthy adults were collected and genomic DNAs of peripheral blood were extracted. Mutation screenings of LKB1 were performed using MLPA (multiplex ligation-dependent probe amplification), PCR, direct sequencing, and PCR-DHPLC (denaturing high-performance liquid chromatography). RESULTS A total of 12 kinds of germline mutations were found in 9 familial PJS patients, most of which were point mutations (7/12); 4 large deletions of LKB1 were also observed. Of the 12 mutations, 7 were pathogenic (2 were de novo), 4 were just polymorphisms, and 1 was indefinitely pathogenic. No pathogenic mutation in exons of the LKB1 gene was detected in the 5 sporadic PJS patients. The mutation detection rate for the LKB1 gene was 85.7% in our Chinese familial PJS and 63.2% in all Chinese PJS patients. Eight familial PJS patients were identified with pathogenic germline mutations in 14 unrelated families (57.1%). Further methylation detection and analysis showed promoter methylation in carcinomatous polyps. CONCLUSIONS LKB1 gene germline mutation with pathogenic effect is a common cause of familial PJS in Chinese patients; however, it is not the only molecular pathogen of PJS. Methylation in the LKB1 gene promoter region may cause carcinomatous change in intestinal polyps.

Indexed as

AdultAMP-Activated Protein Kinase KinasesAsian PeopleChinaExonsFemaleGenetic TestingGerm-Line MutationHumansMaleMethylationMutationPeutz-Jeghers SyndromeProtein Serine-Threonine KinasesQuality of LifeSequence DeletionAMP-Activated Protein Kinase KinasesProtein Serine-Threonine KinasesSTK11 protein, human

Identifiers

PMID27721366
PMCPMC5070620
OpenAlexW2530544438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.